Thumbnail Image
Publication

Benzylmorpholine Analogs as Selective Inhibitors of Lung Cytochrome P450 2A13 for the Chemoprevention of Lung Cancer in Tobacco Users

Blake, Linda Cherise
; 
Roy, Anuradha
; 
Neul, David
; 
Schoenen, Frank J.
; 
Aubé, Jeffrey
; 
Scott, Emily E.
Citations
Altmetric:
Abstract
PURPOSE 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), one of the most prevalent and procarcinogenic compounds in tobacco, is bioactivated by respiratory cytochrome P450 (CYP) 2A13, forming DNA adducts and initiating lung cancer. CYP2A13 inhibition offers a novel strategy for chemoprevention of tobacco-associated lung cancer. METHODS Twenty-four analogs of a 4-benzylmorpholine scaffold identified by high throughput screening were evaluated for binding and inhibition of both functional human CYP2A enzymes, CYP2A13 and the 94%-identical hepatic CYP2A6, whose inhibition is undesirable. Thus, selectivity is the major challenge in compound design. RESULTS A key feature resulting in CYP2A13-selective binding and inhibition was substitution at the benzyl ortho position, with three analogs being >25-fold selective for CYP2A13 over CYP2A6. CONCLUSIONS Two such analogs were negative for genetic and hERG toxicities and metabolically stable in human lung microsomes, but displayed rapid metabolism in human liver and in mouse and rat lung and liver microsomes, likely due to CYP2B-mediated degradation. A specialized knockout mouse mimicking the human lung demonstrates compound persistence in lung and provides an appropriate test model. Compound delivered by inhalation may be effective in the lung but rapidly cleared otherwise, limiting systemic exposure.
Description
The original publication is available at www.springerlink.com
Date
2013-09
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Verlag
Collections
Medicinal Chemistry Scholarly Works
Show all metadata
Files
Thumbnail Image
Scott_2013.pdf
Adobe PDF, 1.05 MB
Research Projects
Organizational Units
Journal Issue
Keywords
Cytochrome P450 2A13, Cytochrome P450 2A6,Tobacco, Lung cancer, Chemopreventative
Citation
Blake, L. C., Roy, A., Neul, D., Schoenen, F. J., Aubé, J., & Scott, E. E. (2013). Benzylmorpholine Analogs as Selective Inhibitors of Lung Cytochrome P450 2A13 for the Chemoprevention of Lung Cancer in Tobacco Users. Pharmaceutical Research, 30(9), 2290–2302. http://doi.org/10.1007/s11095-013-1054-z
URI
https://hdl.handle.net/1808/24672
DOI
10.1007/s11095-013-1054-z
Embedded videos